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Abstract
Introduction: Back pain, a significant source of morbidity in our society, is related to the degenerative changes of
the intervertebral disc. At present, the treatment of disc disease consists of therapies that are aimed at
symptomatic relief. This shortcoming stems in large part from our lack of understanding of the biochemical and
molecular events that drive the disease process. The goal of this study is to develop a model of early disc
degeneration using an organ culture. This approach is based on our previous studies that indicate that organ
culture closely models molecular events that occur in vivo in an ex vivo setting.
Methods: To mimic a degenerative insult, discs were cultured under low oxygen tension in the presence of TNF-a,
IL-1b and serum limiting conditions.
Results: Treatment resulted in compromised cell survival and changes in cellular morphology reminiscent of
degeneration. There was strong suppression in the expression of matrix proteins including collagen types 1, 2, 6
and 9, proteoglycans, aggrecan and fibromodulin. Moreover, a strong induction in expression of catabolic matrix
metalloproteinases (MMP) 3, 9 and 13 with a concomitant increase in aggrecan degradation was seen. An inductive
effect on NGF expression was also noticed. Although similar, nucleus pulposus and annulus fibrosus tissues showed
some differences in their response to the treatment.
Conclusions: Results of this study show that perturbations in microenvironmental factors result in anatomical and
gene expression change within the intervertebral disc that may ultimately compromise cell function and induce
pathological deficits. This system would be a valuable screening tool to investigate interventional strategies aimed
at restoring disc cell function.
Introduction
Intervertebral disc (IVD) degeneration is believed to be
one of the major underlying causes of spinal pathology.
Low back conditions are ubiquitous, accounting for
approximately $100 billion in direct health care-related
costs in the US in 2008 [1,2]. Published reports estimate
a higher prevalence of degenerative discs as age
increases, and nearly 90% of people over 60 years have
at least one degenerative disc on a magnetic resonance
imaging [3]. Clinical manifestations stemming from IVD
degeneration vary based on the grade of degeneration
and associated spinal pathology.
IVD degeneration typically occurs through a progres-
sive and stepwise cascade of events which results from
the alteration of cellular and extracellular matrix com-
position of the nucleus pulposus (NP) and annulus
fibrosus (AF) [4,5]. Early changes in human disc degen-
eration often occur at the cellular level without an
appreciable disruption of the native disc architecture. As
the degenerative cascade progresses, structural abnorm-
alities appear within the disc, resulting in macroscopic
changes and compensatory healing responses. Higher-
grade degenerative processes often lead to clinically evi-
dent conditions that may require medical or surgical
management. Current research attempts at investigating
disc degeneration have focused on models thought to
represent the late-stage degenerative changes [6-16].
Inevitably, induction of the degenerative cascade in
these models requires the mechanical disruption of the
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© 2011 Ponnappan et al.; licensee BioMed Central Ltd.AF and creating structural and morphological changes
that mimic late degeneration [15-17]. This naturally
results in the inability to focus on early cellular and
molecular changes. Other models have described the
use of supra-physiological mechanical loading of func-
tional spinal units with external apparatus [18]. While
this type of approach does not disrupt the annulus,
achievement of controlled and consistent degeneration
may rely on uniformity of mechanical loading, require
longer induction periods, and bring higher costs often
associated with in vivo studies.
As an alternative to some of the in vivo models, other
studies have described disc organ culture systems to
investigate disc degeneration [17,19-25]. Some of these
reports are feasibility studies designed to describe and
characterize techniques to maintain a viable disc organ
culture [17,19,21], whereas other studies use enzymatic
digestion of the proteoglycan matrix or needle puncture
injury to replicate the cellular and architectural changes
that occur during disc degeneration without intrinsic
action of proinflammatory and catabolic mediators (as
postulated in human degenerative disc disease, or DDD)
[25-27]. To the best of our knowledge, our study is the
f i r s ta t t e m p tt or e p o r ta nin vitro model that induces
physiological disc degeneration and allows the investiga-
tion of early disc degeneration without annulus
disruption.
Materials and methods
Disc harvesting and organ culture
Animal experiments were approved by the Institutional
Animal Care and Use Committee. Wistar rats (250 to
300 g; Charles River Laboratories International, Inc.,
Wilmington, MA, USA) were euthanized with CO2 and
the spinal columns were removed en bloc under aseptic
conditions. Lumbar IVDs comprising the vertebral end-
plates, AF and NP were harvested (six discs per animal).
Soft tissues and posterior elements were removed, and
discs were rinsed in saline solution before being placed
in 48-well culture plates. All experimental specimens
were cultured in an hypoxia workstation (Invivo2;R u s -
kinn Technology Ltd, Pencoed, UK) in 1% O2,5 %C O 2,
and 93% N2 in Dulbecco’s modified Eagle’sm e d i u m
(DMEM) containing 1% fetal bovine serum (FBS), tumor
necrosis factor-alpha (TNF-a) 100 ng/mL, interleukin-
1beta (IL-1b) 10 ng/mL (R&D Systems, Inc., Minneapo-
lis, MN, USA), 50 μg/mL L-ascorbate, 40 mM NaCl,
antibiotics, and antimycotics (Cellgro; Mediatech, Inc.,
Manassas, VA, USA). Concentration of cytokines was
based on the literature [28,29]. Importantly, slightly
higher doses of cytokines were chosen to compensate
for the lack of systemic feedback present from immune
and neuronal cells during degeneration. Control groups
were cultured in DMEM containing 20% FBS, 50 μg/mL
L-ascorbate, 40 mM NaCl, and antibiotics. The discs
were maintained for 3 and 10 days. The complete med-
ium was replaced every 2 days for all groups.
Assessment of molecular diffusion
To measure the diffusion in the organ-cultured discs, 5
to 10 μg/mL of QuantiLum Firefly luciferase (61 kDa)
(Promega Corporation, Madison, WI, USA) and 50 to
100 μg/mL of Renilla luciferase (38 kDa) (Prolume Ltd.,
Pinetop, AZ, USA) were added to the medium. After 24
hours in culture, discs were immersed in Hank’s
balanced salt solution supplemented with 40 mM NaCl.
An incision was made through the middle of the AF
with #15 scalpel blades, and the two halves of the disc
were opened. The NP was then scooped out with a
Meyhoefer Curette (World Precision Instruments, Sara-
sota, FL, USA) (Figure 1A). Tissue was harvested, and a
Dual-Luciferase Reporter Assay System (Promega Cor-
poration) was used for measurements of Firefly and
Renilla luciferase. Quantification was carried out with a
luminometer (TD-20/20; Turner Designs, Sunnyvale,
CA, USA). All analysis was carried out in triplicate.
Assessment of apoptosis
For in situ identification of apoptotic cells, a TACS 2
TdT-Fluor In Situ Apoptosis Detection Kit was used on
histological sections in accordance with the instructions
of the manufacturer (TrevigenI n c . ,G a i t h e r s b u r g ,M D ,
U S A ) .I nb r i e f ,8 - μm tissue sections from paraffin-
embedded discs were deparaffinized in xylene, rehy-
drated, and pretreated with proteinase K solution for 15
minutes at 37°C. The slides were rinsed twice in deio-
nized water and incubated with 50 μL of labeling reac-
tion mixture for 1 hour at 37°C in a humidified
chamber. After washing with phosphate-buffered saline
(PBS), 50 μL of Strep-Fluor solution was applied, and
the slides were incubated for 20 minutes. The slides
were washed three times in PBS and mounted under
glass coverslips using fluorescence mounting media
(Vector Laboratories, Burlingame, CA, USA) and ana-
l y z e du n d e raf l u o r e s c e n c em i c r o s c o p eu s i n ga4 9 5 - n m
filter (Nikon eclipse TE 2000-U; Nikon, Tokyo, Japan).
Histology and immunohistochemistry
Whole disc units, including the endplates, were fixed in
10% formaldehyde in PBS for routine histological and
immunohistochemical evaluation. After fixation, disc
units were serially dehydrated in alcohol. Decalcification
was accomplished with 12.5% ethylenediaminetetraacetic
acid (EDTA) (pH 7.4) followed by paraffin embedding.
The tissue blocks were sectioned parallel to the endplate
(6 to 8 μm in thickness), and sections were deparaffi-
nized in xylene and rehydrated through graded ethanol
and stained with Alcian blue, eosin, and hematoxylin.
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Figure 1 Establishment of organ culture model of disc degeneration. (A) Schematic showing disc organ culture setup. Culturing discs
under low oxygen partial pressure (pO2) in hyperosmolar, nutritionally limiting media and exposure to proinflammatory cytokines mimic
molecular changes characteristic of early disc degeneration. NP, nucleus pulposus; AF, annulus fibrosus; FBS, fetal bovine serum. (B,C)
Measurement of luciferase diffusion in nucleus pulposus (NP) tissue after 24 hours. Both Firefly (61 kDa) and Renilla (38 KDa) luciferase diffuse in
the tissue in a concentration-dependent fashion. Results are shown as the mean ± standard error for three independent experiments performed
in triplicate. *P <0.05. (D) Histological sections were stained for apoptotic cells. Tumor necrosis factor-alpha (TNF-a)-treated and interleukin-1beta
(IL-1b)-treated intervertebral discs demonstrated significantly higher numbers of apoptosis-positive cells (d) than the untreated control group (b)
after 3 days in culture (DAPI: a and c). Ctr., control group; DAPI, 4’-6-diamidino-2-phenylindole; Exp., experimental group; TUNEL, terminal
deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling. (E) Histological analysis of disc after treatment. Sections are stained with
Alcian blue and hematoxylin-and-eosin counter staining and photographed with a low-magnification (4×) lens (a). Panels (b) and (c) were
examined under high magnification (20×). Aberrant cellular hypertrophy and matrix degradation of NP tissue in treated disc were observed after
3 and 10 days. Representative findings of three separate experiments (n = 3 discs/group per experiment) are shown.
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tions were incubated with rabbit monoclonal MMP-3
antibody (EP1186Y; Abcam, Cambridge, MA, USA) in
2% bovine serum albumin in PBS at a dilution of 1:250
at 4°C overnight. After washing of the sections, the
bound primary antibody was incubated with Alexa
fluor-488 conjugated anti-rabbit secondary antibody
(Invitrogen Corporation, Carlsbad, CA, USA) at a dilu-
tion of 1:100 for 1 hour at room temperature. Sections
were mounted in mounting media containing DAPI
(4’,6’ diamino-2-phenylindole) and visualized with a
fluorescence microscope (Olympus, Tokyo, Japan).
RNA extraction and quantitative real-time polymerase
chain reaction
The discs were collected and the AF was separated from
the NP. The tissues were stabilized in RNA later in
accordance with the instructions of the manufacturer
(Ambion, Inc., Austin, TX, USA) and stored at −80°C.
Total RNA was extracted with an RNeasy Micro kit in
accordance with the instructions of the manufacturer
(Qiagen Inc., Valencia, CA, USA). The DNA template
from the RNA preparation was removed by using the
DNase I digestion. cDNAs were made by using 0.5 μgo f
total RNA, and quantitative real-time reverse transcrip-
tion-polymerase chain reaction (RT-PCR) was per-
formed with SYBR Green PCR Master Mix (Applied
Biosystems, Foster City, CA, USA) on an ABI 7900 HT
sequence detection system. PCR was initiated at 95°C
for 10 minutes (to activate the AmpliTaq polymerase)
followed by a 40-cycle amplification phase (95°C for 15
seconds, anneal/extend at 60°C for 60 seconds). Melting
curve analysis was performed to ensure specific PCR
product while excluding primer dimers. The data were
normalized to the endogenous control, 18S rRNA mes-
sage, in each sample and were represented as a relative
change to the control. All of the primers used were
synthesized by Integrated DNA Technologies, Inc. (Cor-
alville, IA, USA). Sequences for primers are presented in
Table 1.
Western blot
Expression of aggrecan degradation products, MMP-3,
MMP-9, and MMP-13 were evaluated by means of Wes-
tern blot analysis. AF and NP tissue was washed with
cold PBS and was extracted with lysis buffer (Cell Sig-
naling Technologies, Danvers, MA, USA) at 4°C for 24
hours. The lysis buffer contains the following: 20 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1
mM EGTA (ethylene glycol tetraacetic acid), 1% Triton,
2.5 mM sodium pyrophosphate, 1 mM b-glyceropho-
sphate, 1 mM sodium vanadate (Na3VO4), 1 μg/mL leu-
peptin, 1 mM PMSF (phenylmethylsulfonyl fluoride),
and 1X complete protease inhibitors (Roche Molecular
Biochemicals, Indianapolis, IN, USA). The tissue lysate
was centrifuged for 10 minutes at 14,000g to collect the
clear tissue extract. Protein concentration in the extract
was determined by using a Pierce BCA protein assay kit
(Thermo Fisher Scientific Inc., Rockford, IL, USA). To
detect aggrecan core protein fragments, lysates were
treated with chondroitinase ABC (Sigma-Aldrich, St.
Louis, MO, USA) 0.1 U/mL in 50 mM Tris-acetate
EDTA buffer at 37°C for 1 hour. Protein extracts (10
μg) were centrifuged at 4°C for 2 minutes at 14,000g
and resolved on NuPAGE 4-12% Bis-Tris Gels (Invitro-
gen Corporation). Proteins were transferred onto Immo-
bilon-P Membrane (Millipore Corporation, Billerica,
MA, USA). The membrane was blocked with 5% nonfat
dry milk in PBS with 0.1% Tween-20 and incubated
overnight at 4°C in 3% nonfat dry milk in PBS with
0.1% Tween-20 with appropriate antibody (mouse
monoclonal [BC-3] to aggrecan ARGxx, rabbit monoclo-
nal [EP1186Y] to MMP-3, rabbit monoclonal [EP1254]
to MMP-9, and rabbit polyclonal to MMP-13; all from
Abcam). The binding of the secondary antibody was
Table 1 Primers used for real-time reverse transcription-
polymerase chain reaction
Target genes Sequence (5’ to 3’) Size, base pairs
F: TGGCCAAGAAGACATCCCTGAAGT
Collagen type 1 R: ACATCAGGTTTCCACGTCTCACCA 81
F: GAGTGGAAGAGCGGAGACTACTG
Collagen type 2 R: CTCCATGTTGCAGAAGACTTTCA 81
F: TTCATGCATCCGCTAGTCCCTTCT
Collagen type 6 R: CCTTTATTGGGCCATTGGGCATGT 136
F: TCGTGGATGTGGTGCTGAAGATGA
Collagen type 9 R: ATTGGGTCCCTGTTTGCCTGGATA 146
F: TGTCCAACAACCTGTGGAGGAAGA
Fibromodulin R: CGTTGTGTGTGTGTGTGTGTGTGT 113
F: AAGGACTGTCTATCTGCACGCCAA
Aggrecan R: TCACCACCCACTCCGAAGAAGTTT 126
F: ATTGGCACAAAGGTGGATGCTGTC
MMP-3 R: ACGACGCCTTCCATGGATCTTCTT 160
F: TTCTCGAATCACGGAGGAAGCCAA
MMP-9 R: AAGGCTGAGTTCAACTTTGCAGGC 89
F: ACTTGTGTGACAGGAGCTAAGGCA
MMP-13 R: AGGAGCATGAAAGGGTGGTCTCAA 119
F: CTGGCCAATGGCATGGATCTCAAA
TNF-a R: ATGAAATGGCAAATCGGCTGACGG 148
F: ACCTGCTAGTGTGTGATGTTCCCA
IL-1b R: AGGTGGAGAGCTTTCAGCTCACAT 109
F: ACTTCCAGGCCCATGGTACAATCT
NGF R: TTGATGTCCGTGGCTGTGGTCTTA 148
F: AGTCCCTGCCCTTTGTACACA
18S R: GATCCGAGGGCCTCACTAAAC 68
F, forward primer; R, reverse primer; IL-1b, interleukin-1beta; MMP, matrix
metalloproteinase; NGF, nerve growth factor; TNF-a, tumor necrosis factor-
alpha.
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GE Healthcare, Little Chalfont, Buckinghamshire, UK).
Results were normalized to the content of tubulin
detected with monoclonal antibody beta-tubulin (E7;
Developmental Studies Hybridoma Bank at the Univer-
sity of Iowa, Iowa City, IA, USA).
Data analysis
Data were represented as mean ± standard error from
three independent experiments. Statistical analysis was
performed with Sigma Plot 11.2 statistical software
(Systat Software, Inc., San Jose, CA, USA). Student t test
or, where appropriate, Mann-Whitney test was used to
measure statistical significance (P <0.05).
Results
Characterization of molecular transport in organ culture
To characterize the diffusion of proteins of different
molecular-weight proteins in the organ culture disc, we
incubated discs with Firefly (61 kDa) and Renilla (38
kDa) luciferase (Figure 1A). After 24 hours of incuba-
tion, the NP was dissected and analyzed for the lucifer-
ase activity. Both the Firefly and Renilla luciferase show
an increase in luminescence in a concentration-depen-
dent manner within the NP (Figure 1B,C).
Assessment of cellular apoptosis and morphological
changes
To ensure that our model reflects cellular and histologi-
cal changes often seen with early disc degeneration, an
assessment of cell viability was performed with the
TUNEL (terminal deoxynucleotidyl transferase dUTP
nick end labeling) assay. Figure 1D shows that TNF-a
and IL-1b treatment for 3 days results in an increase in
the number of apoptotic cells (Figure 1D-d) both in the
NP and AF in comparison with the untreated control
discs (Figure 1D-b). We performed a histological analy-
sis of the organ-cultured discs to assess changes in cel-
lular morphology and tissue organization (Figure 1E).
Control untreated discs showed lamellar organization of
the AF with well-circumscribed NP containing abundant
proteoglycan-rich Alcian blue-stained extracellular
matrix. NP cells showed well-defined eosinophilic cyto-
sol with prominent cell nuclei. After 3 days of treatment
with TNF-a and IL-1b, the discs demonstrated a nota-
ble loss of eosinophilic staining of the cytoplasm of the
central NP cells. Although tissue architecture was pre-
served, a decrease in the Alcian blue staining of the
extracellular matrix was noted with signs of cell loss
and a concomitant increase in vacuole formation. At 10
days after treatment, additional changes of the cellular
architecture were observed; the most obvious was a loss
of Alcian blue staining of the extracellular matrix. Addi-
tionally, the eosinophilic staining of the NP cytosol was
nearly gone and lacunae previously occupied by cells
were empty. AF architecture, however, was preserved
throughout the 10 days of treatment (Figure 1E, bottom
row).
Changes in gene expression
Downregulation of critical matrix genes
Real-time RT-PCR was used to determine the effect of
proinflammatory cytokines TNF-a and IL-1b and lim-
ited nutrition on the expression of both anabolic and
catabolic regulators of disc homeostasis. A significant
d e c r e a s ew a ss e e ni nc o l l a g e nt y p eI ,c o l l a g e nt y p eI I ,
and collagen type VI expression by both NP and AF
cells after 3 and 10 days of treatment (Figure 2A-C).
Interestingly, collagen type IX expression decreased in
only the AF at 10 days (Figure 2D). To investigate
changes in expression of important proteoglycan
matrix components of the tissues, we studied the
expression pattern of aggrecan and fibromodulin and
found a significant downregulation in both the NP and
AF after 3 and 10 days in organ culture (Figure 3A,B).
To investigate whether a decrease in aggrecan expres-
sion is coupled with an increase in aggrecan break-
down, Western blot analysis of NP and AF tissue
lysates was performed. Owing to the lower cellularity
of the AF in comparison with the NP tissue, a smaller
proportion of cellular protein was observed for AF.
Figure 3C shows that, in treated samples, anti-ARGxx
antibody detects additional cleaved aggrecan core pro-
tein fragments in comparison with untreated controls
(arrow).
Upregulation in catabolic gene expression
We performed an analysis to investigate whether treat-
ment with cytokines and nutritional deficiency results in
upregulation of genes encoding catabolic enzymes. Fig-
ures 4A and 4B show a significant induction in MMP-3
expression in NP and AF tissues at 3 and 10 days after
treatment. Expression of MMP-3 after 3 days of treat-
ment was also analyzed by Western blot analysis (Figure
4C). Interestingly, the increase in MMP-3 protein
expression is more prominent in the AF tissue in com-
parison with the NP. Immuoflorescence analysis was
used to confirm the expression and localization of
MMP-3 in the treated discs. Figure 4D shows a positive
staining of MMP-3 in NP and AF cells. Outer AF cells
demonstrate enhanced expression of MMP-3 in compar-
ison with inner AF cells. We then examined expression
of MMP-9 and MMP-13 in treated discs (Figure 5A,B).
Similar to MMP-3, both MMP-9 and MMP-13 show
increased mRNA expression in both of the tissues (Fig-
ure 5A,B). Western blot analysis was also used to mea-
sure MMP-9 and MMP-13 expression in disc tissues.
Figure 5C shows a significant induction in MMP-9 in
AF cells of the treated disc and a smaller increase in
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Page 5 of 12MMP-9 expression in the NP tissue. In contrast to
MMP-9 protein, MMP-13 protein shows a prominent
increase in NP when compared with the AF tissue (Fig-
ure 5D). Overall, these results demonstrated an
enhanced expression of catabolic MMPs in the disc
after the treatment.
Changes in expression of genes that are associated with
pain and inflammation
Since the disc organ culture is an in vitro system, a
direct assessment of pain and inflammation without the
involvement of neuronal and immunological compo-
nents is not feasible. However, to get an indirect
assessment of whether the degenerative changes in the
discal tissues elicit changes in the expression of genes
that activate neuronal and immune components result-
ing in pain and inflammation changes in expression of
m a r k e rg e n e ss u c ha sn e r v eg r o w t hf a c t o r(NGF), TNF-
a,a n dIL-1b were measured. Figures 6A and 6B show
that 3 days of treatment results in increased NGF
expression by the NP and the AF. This increase in
expression is sustained in the NP tissue at 10 days,
whereas a small decrease is noticed in the AF. Interest-
ingly, whereas IL-1b demonstrated a strong increase in
both tissues (Figure 6C), TNF-a exhibits a small
decrease in expression after treatment (Figure 6D).
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Figure 2 C o l l a g e ng e n ee x p r e s s i o ni ss u p p r e s s e di no rgan culture model of disc degeneration. Expression of important disc matrix
collagens decreases with tumor necrosis factor-alpha, interleukin-1beta, and limited nutrition. Expression of type 1 collagen (COL1) and type 2
collagen (COL 2) is significantly suppressed in (A) nucleus pulposus (NP) and (B) annulus fibrosus (AF) tissues of treated discs at 3 and 10 days.
Note a significant decrease in type 6 collagen (COL 6) after the treatment in (C) NP and (D) AF. Type 9 collagen (COL 9) expression is decreased
only in AF after 10 days of treatment (C,D). Results are shown as the mean ± standard error for three independent experiments (n = 6 discs/
group per experiment). *P <0.05. Ctr., control group; Exp, experimental group.
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T h eu b i q u i t o u sp r e s e n c eo fs y m p t o m a t i cD D Di sa n
increasing clinical problem with few reliable treatments.
The etiology of DDD is likely multifactorial and remains
elusive. Current surgical treatment options for DDD are
based on the end-stage changes of the degenerative disc
complex with or without concomitant neural compres-
sion or instability or both. Medical (non-surgical) man-
agement of DDD (specifically discogenic low back pain)
centers around symptom relief with supportive mea-
sures, whereas surgical management focuses on ablation
and reconstruction of the pathological disc. Currently,
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Figure 3 Matrix gene expression is altered in organ culture model of disc degeneration. Real-time reverse transcription-polymerase chain
reaction analysis of aggrecan (AGG) and fibromodulin after treatment. There is a significant downregulation in expression of AGG and
fibromodulin (Fmod) mRNA in (A) nucleus pulposus (NP) and (B) annulus fibrosus (AF) tissues of treated discs. Results are shown as the mean ±
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Page 7 of 12no specific cure exists to halt or reverse the pathological
processes that result in disc degeneration. Therefore, to
understand the degenerative process at the molecular
level for devising a biologic solution, a reliable model to
investigate the cellular changes that initiate disc
degeneration is needed. Such a model will assist in eval-
uating treatments that may be able to halt or reverse
the early degenerative process.
Several animal-based models of DDD have been
described in the literature and employ various techniques
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Figure 4 Catabolic gene expression is upregulated by tumor necrosis factor-alpha, interleukin-1beta, and limited nutrition. Expression
of matrix metalloproteinase 3 (MMP-3) mRNA in nucleus pulposus (NP) (A) and annulus fibrosus (AF) (B) tissues. Expression is significantly
induced in both tissues after the treatment for 3 and 10 days. Results are shown as the mean ± standard error for three independent
experiments (n = 6 discs/group per experiment). *P <0.05. (C) Western blot analysis of MMP-3 in NP and AF tissue lysates after 3 days in culture
confirms the expression of MMP-3. (D) Representative photomicrographs of the immunohistochemical reactivity for MMP-3 in tissue sections
from treated discs for 3 days (c,d). Sections were also stained with Alcian blue and hematoxylin and eosin (HE) for visualization of morphological
details (a,b). Owing to extremely low signal intensity, data for untreated tissue sections are not shown. Original magnification: 20×. (E) The
expression of MMP-3 tends to increase in the experimental group. Ctr., control group; Exp, experimental group.
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Page 8 of 12to induce degeneration. Currently, the most commonly
used strategies involve in vivo techniques with mechanical
disruption of the AF [6,9,12,15-17,30], mechanical stress
of the functional spine unit [18], or chemical degradation
of the NP [8,31]. Other models capitalize on the natural
occurrence of advanced DDD in that species [32].
Regardless, the existing models are geared primarily
toward mimicking the advanced degenerative changes
resembling grade 4 or 5 human discs on the Pfirrmann
scale. Although a few in vitro organ culture models that
use injury or chemicals to replicate cellular and molecular
changes seen during disc degeneration have been reported
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Figure 5 Effect of tumor necrosis factor-alpha, interleukin-1beta, and limited nutrition on matrix metalloproteinase (MMP)-9 and MMP-
13 expression. Expression analysis of MMP-9 and MMP-13 mRNA in nucleus pulposus (NP) (A) and annulus fibrosus (AF) (B) tissues after the
treatment. Both MMP-9 and MMP-13 are significantly upregulated after the treatment. Results are shown as the mean ± standard error for three
independent experiments (n = 6 discs/group per experiment). *P <0.05. Western blot analysis of MMP-9 (C) and MMP-13 (D) in NP and AF tissue
lysates after 3 days in culture. The expression of MMP-9 (E) and MMP-13 (F) is increased in the treated samples. Ctr., control group; Exp,
experimental group.
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Page 9 of 12[24-26], a true atraumatic model that attempts to charac-
terize the early stages of DDD (Pfirrmann grade 1 to 3)
has not been available. As described in this study, an
atraumatic in vitro model of disc degeneration uses pertur-
bations in several important microenviromental factors
that are known to occur during degenerative cascade. The
model allows an analysis of reproducible and quantifiable
effects at the cellular level by using gene expression, pro-
tein analysis, and histology. Another advantage is that this
model offers differential analysis of the AF and the NP.
Our organ culture DDD model allows analysis of cel-
lular changes that occur in degenerative discs prior to
injury or disruption of the AF. Using chemical
proinflammatory cytokines and conditions that mimic
the normal internal disc milieu (hypoxia, hyperosmolar-
ity, and decreased nutrients), our model shows altera-
tions in gene expression, protein expression, and
histological disc architecture resembling human degen-
erative discs in grade 1 or 2. Gene expression analysis
shows downregulation of important extracellular matrix
components, including collagen types 1, 2, 6, and 9 and
fibromodulin. A similar decline is seen in the expression
of the major proteoglycan aggrecan, indicating a slow-
down of the anabolic or matrix maintenance phase as
seen in human DDD [33,34]. Furthermore, significant
induction in expression of MMP-3, -9, and -13, enzymes
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Figure 6 Tumor necrosis factor-alpha (TNF-a), interleukin-1beta (IL-1b), and limited nutrition causes changes in expression of genes
associated with pain and inflammation. Nucleus pulposus (NP) (A) and annulus fibrosus (AF) (B) were analyzed at the indicated days for
nerve growth factor (NGF) expression by using quantitative reverse transcription-polymerase chain reaction (RT-PCR). At 3 days of treatment, NGF
is significantly increased in NP and AF. At 10 days after treatment, the expression of NGF in NP was significantly increased but in AF showed a
lower expression compared with the control. Expression analysis of TNF-a and IL-1b genes showed decreased expression of TNF-a after
treatment in NP (C) and AF (D) tissues. IL-1b showed an increase in expression compared with untreated control. Results are shown as the mean
± standard error for three independent experiments (n = 6 discs/group per experiment). *P <0.05. Ctr., control group; Exp, experimental group;
ns, not significant.
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humans, shows promotion of a catabolic state [35-37].
Importantly, Western blot analysis confirmed the pre-
sence and upregulation of degradative enzymes (aggre-
canase and MMPs), indicating upregulation not only at
the mRNA level but also at the protein level. These
results strongly support the notion that early phases of
disc degeneration are characterized not only by a
decrease in synthetic activity of cells but also by a con-
comitant increase in production of the mediators that
promote a catabolic environment within the disc.
The most compelling piece of data that substantiates
this model is the histology of the discs at 3 and 10
days after treatment. The progressive loss of the pro-
teoglycan-rich extracellular matrix and changes in cel-
lular morphology and architecture closely resemble
DDD in humans. As expected, this phenomenon pro-
gressively worsens with treatment duration. Although
t h ed i s ca r c h i t e c t u r er e s e m b l e sag r a d e3d i s ci n
humans at 10 days after treatment, eosinophilic cyto-
plasm continues to be seen within the NP, indicating
the presence of viable cells. Regardless of treatment
duration, significant annular disruption at the struc-
tural level was not noted in any of the specimens, indi-
cating a state reminiscent of the early stage of disease
in humans. It should be noted that the rat organ cul-
ture described here, despite several similarities with
the human pathological state, lacks true mechanical
loading, although medium osmolarity is raised to
mimic loading conditions and to counteract swelling.
Therefore, while extrapolating the results from this rat
organ culture system to the humans, it would be pru-
dent to consider the inherent differences in tissue size,
diffusional distances, and cellular morphology and
composition between the species.
Conclusions
This study describes an atraumatic in vitro model to
investigate cellular and molecular events associated with
IVD degeneration by using a rat disc in organ culture.
This model may prove useful to those seeking an atrau-
matic model to use for investigations of early DDD
mechanisms and treatment.
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